Sinovac Biotech

$6.47
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today
$0.00 (0.00%) As of 8:00 PM UTC after-hours

Why Robinhood?

You can watch SVA and buy or sell other stocks, options, and ETFs commission-free!

About SVA

Sinovac Biotech, Ltd. Ordinary Shares, also called Sinovac Biotech, is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China. The listed name for SVA is Sinovac Biotech, Ltd. Ordinary Shares.

CEO
Wei Dong Yin
Employees
910
Headquarters
Beijing, Beijing
Founded
1993
Market Cap
460.25M
Price-Earnings Ratio
41.69
Dividend Yield
Average Volume
High Today
Low Today
Open Price
Volume
0.00
52 Week High
$8.75
52 Week Low
$5.73

Collections

SVA News

ReutersDec 3

Brazil gets Chinese COVID-19 vaccine doses, Senate OK's British vaccine funding

SAO PAULO (Reuters) - São Paulo’s Butantan Institute biomedical center on Thursday received 1 million doses of a Chinese COVID-19 vaccine developed by Sinovac B

SVA Earnings

-$0.07
$0.02
$0.12
$0.21
Q4 FY18
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
Expected Dec 18, Pre-Market

You May Also Like